About this journal

Medicinal chemistry has evolved rapidly into a highly interdisciplinary field, enriched by the collaborative efforts of experts from a wide spectrum of specialist areas, from chemoinformaticians and physical chemists to molecular biologists and pharmacologists. Future Medicinal Chemistry provides a regular point of access to commentary and debate for this ever-expanding and diversifying community. The journal showcases milestones in pharmaceutical R&D and features expert analysis of emerging research-from the identification of targets, through to the discovery, design, synthesis and evaluation of bioactive agents.

There has never been more pressure to produce potent and safe compounds faster and more efficiently. Future Medicinal Chemistry offers a forum for the rapid publication of original research and critical reviews of the latest milestones in the field. Strong emphasis is placed on ensuring that the journal stimulates awareness of issues that are anticipated to play an increasingly central role in influencing the future direction of pharmaceutical chemistry. Where relevant, contributions are also actively encouraged on areas as diverse as biotechnology, enzymology, green chemistry, genomics, immunology, materials science, neglected diseases and orphan drugs, pharmacogenomics, proteomics and toxicology.

Principal themes include:

• Drug discovery technologies
• Design and synthesis of novel lead compounds
• Computational approaches to synthesis and modeling
• Biophysical techniques for structural characterization
• Overviews of novel therapeutic strategies and emerging targets
• Drug targeting and delivery
• ADME/Tox investigations
• Commentary on science policy, economic and IP issues

In addition to its core content of Reviews, Patent Reviews, Perspectives and Original Research, the journal also features enlightened commentary and opinion on topical areas of debate relevant to academia and industry, as well as conference reports, interviews and more.

By remaining highly responsive to emerging themes, and providing in-depth analysis of agents of medicinal interest and therapeutic approaches, the journal will act as a valuable reference, not only for medicinal chemists, but for all those interested in the advancement of pharmaceutical science.

The journal welcomes unsolicited article proposals.

Senior Editors

Baell J, Monash University, Australia
Ojima I, State University of New York at Stony Brook, USA

Associate Editors

Albericio F,University of Barcelona, Spain
Golding B, University of Newcastle, UK
Honek JF,University of Waterloo, Canada
Laughton C, University of Nottingham, UK
Mátyus P, Semmelweis University, Hungary
Ramachandran PV, Purdue University, USA
Reynolds CA, University of Essex, UK
Ruan K, University of Houston, USA
Thurston DE, King’s College London, UK
Woodard RW, University of Michigan, USA

Advisory Board

Baldwin JJ, Cleo Pharmaceuticals, USA
Blagg BSJ, University of Kansas, USA
Bolognesi ML, University of Bologna, Italy
Chauhan PMS, Central Drug Research Institute, Lucknow, India
Costantino L, University of Modena, Italy
Cottens S, Novartis Inst. for BioMedical Research, Switzerland
d’Alarcao M, San José State University, USA
Eaton M, ETPN & University of Nottingham, UK
Ecker G, University of Vienna, Austria
Ferguson DM, University of Minnesota, USA
Ghosh AK, Purdue University, USA
Gilbert I, University of Dundee, UK
Gold B, University of Pittsburgh, USA
Graczyk PP, Selvita S.A., Poland
Hale KJ, Queen’s University, Belfast, N. Ireland
Harris PA, GlaxoSmithKline, USA
Herdewijn P, Katholieke University Leuven, Belgium
Hrycyna CA, Purdue University, USA
Jacobson KA, NIH, USA
Kaneko T, TB Alliance, USA
Laggner C, Evotec (US) Inc, South San Francisco, USA
Langer T, Prestwick Chemical Inc, France
Ling CC, University of Calgary, Canada
Lowe TL, University of Tennessee Health Science Center, USA
Mason J, University of Bath, UK
Matta CF, Mount St. Vincent University, Canada
McCurdy CR, University of Mississippi, USA
Merz KM, University of Florida, USA
Nicklaus MC, National Cancer Inst. at Frederick, USA
Nikolovska-Coleska Z, University of Michigan, USA
Potter B, University of Oxford, UK
Prisinzano TE, University of Kansas, USA
Richardson D, University of Sydney, Australia
Rigby AC, University of Harvard, USA
Schmidt M, Indiana University, USA
Schneider G, ETH Zurich, Switzerland
Schubert-Zsilavecz M, Johann Wolfgang Goethe-University, Germany
Sheridan RP, Merck Research Laboratories, USA
Sippl W, Martin-Luther-Universität Halle-Wittenberg, Germany
Spencer J, University of Sussex Falmer, UK
Threadgill M, University of Bath, UK
Tortorella M, Guangzhou Institutes of Biomedicine and Health, China
Varnek A, University of Strasbourg, France
Wang S, University of South Australia, Australia
Wiese M, University of Bonn, Germany
Whitty A, Boston University, USA
Xing C, University of Minnesota, USA
Zhu W, Shanghai Institute of Materia Medica, China
Zinzalla G, Karolinska Institute, Sweden